| Uncovering the relationship between YAP/ WWTR1 (TAZ) genes expression and LncRNAs of SNHG15, HCP5 and LINC01433 in breast cancer tissues. | Uncovering the relationship between YAP/ WWTR1 (TAZ) genes expression and LncRNAs of SNHG15, HCP5 and LINC01433 in breast cancer tissues.
Beyrami M, Khodadadi I, Tavilani H, Razavi ANE, Karimi J. | 06/11/2024 |
| [The expression of long non-coding RNA human leukocyte antigen complex P5(lncRNA HCP5) in synovial tissue of patients with rheumatoid arthritis is up-regulated and correlated with immune cell infiltration]. | [The expression of long non-coding RNA human leukocyte antigen complex P5(lncRNA HCP5) in synovial tissue of patients with rheumatoid arthritis is up-regulated and correlated with immune cell infiltration].
Xiao J, Cai X, Huang X, Guo F, Chen X, Hong Y, Yin Z, Ye Z. | 06/2/2023 |
| HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. | HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity.
Nan Y, Luo Q, Wu X, Chang W, Zhao P, Liu S, Liu Z., Free PMC Article | 02/14/2023 |
| LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/beta-catenin/cyclin D1 signaling via PLAGL2. | LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2.
Liu Q, Ran R, Song M, Li X, Wu Z, Dai G, Xia R. | 12/24/2022 |
| Long noncoding RNA HCP5 promotes osteosarcoma cell proliferation, invasion, and migration via the miR-29b-3p-LOXL2 axis. | Long noncoding RNA HCP5 promotes osteosarcoma cell proliferation, invasion, and migration via the miR-29b-3p-LOXL2 axis.
Tan JD, Zhou MF, Yang S, Lin JP. | 10/15/2022 |
| Overexpression of lncRNA HCP5 in human umbilical cord mesenchymal stem cell-derived exosomes promoted the proliferation and inhibited the apoptosis of ovarian granulosa cells via the musashi RNA-binding protein 2/oestrogen receptor alpha 1 axis. | Overexpression of lncRNA HCP5 in human umbilical cord mesenchymal stem cell-derived exosomes promoted the proliferation and inhibited the apoptosis of ovarian granulosa cells via the musashi RNA-binding protein 2/oestrogen receptor alpha 1 axis.
Sun YT, Cai JH, Bao S. | 10/8/2022 |
| Dexmedetomidine Mitigates Myocardial Ischemia/Reperfusion-Induced Mitochondrial Apoptosis through Targeting lncRNA HCP5. | Dexmedetomidine Mitigates Myocardial Ischemia/Reperfusion-Induced Mitochondrial Apoptosis through Targeting lncRNA HCP5.
Deng X, Ye F, Zeng L, Luo W, Tu S, Wang X, Zhang Z. | 08/27/2022 |
| LncRNA HCP5 Participates in the Tregs Functions in Allergic Rhinitis and Drives Airway Mucosal Inflammatory Response in the Nasal Epithelial Cells. | LncRNA HCP5 Participates in the Tregs Functions in Allergic Rhinitis and Drives Airway Mucosal Inflammatory Response in the Nasal Epithelial Cells.
Yang C, Shangguan C, Cai C, Xu J, Qian X., Free PMC Article | 05/21/2022 |
| HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma. | HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Wang Y, Yu Z, Shi W, Shen J, Guan Y, Ni F., Free PMC Article | 04/23/2022 |
| LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling. | LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling.
Xu J, Ma J, Guan B, Li J, Wang Y, Hu S., Free PMC Article | 04/16/2022 |
| Knockdown long non-coding RNA HCP5 enhances the radiosensitivity of esophageal carcinoma by modulating AKT signaling activation. | Knockdown long non-coding RNA HCP5 enhances the radiosensitivity of esophageal carcinoma by modulating AKT signaling activation.
Guo Y, Wang L, Yang H, Ding N., Free PMC Article | 02/26/2022 |
| HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis. | HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
Liang L, Kang H, Jia J., Free PMC Article | 02/12/2022 |
| HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression. | HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression.
Liu Y, Jing XB, Wang ZC, Han QK., Free PMC Article | 02/5/2022 |
| MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis. | MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis.
Chen W, Zhang K, Yang Y, Guo Z, Wang X, Teng B, Zhao Q, Huang C, Qiu Z., Free PMC Article | 01/8/2022 |
| lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR1385p in cutaneous squamous cell carcinoma. | lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
Zou S, Gao Y, Zhang S., Free PMC Article | 12/11/2021 |
| LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis. | LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis.
Wang X, Liu Y, Rong J, Wang K., Free PMC Article | 12/11/2021 |
| Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. | Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
Yin D, Lu X., Free PMC Article | 11/22/2021 |
| Knockdown of long noncoding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR36195p to target HDAC9. | Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9.
Zhu Y, Hao F. | 11/13/2021 |
| T Cell Factor 4 Is Involved in Papillary Thyroid Carcinoma via Regulating Long Non-Coding RNA HCP5. | T Cell Factor 4 Is Involved in Papillary Thyroid Carcinoma via Regulating Long Non-Coding RNA HCP5.
Wang R, Cai J, Xie S, Zhao C, Wang Y, Cao D, Li G., Free PMC Article | 11/6/2021 |
| HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B*57:01 genotyping to predict abacavir hypersensitivity reaction in Spain. | HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B*57:01 genotyping to predict abacavir hypersensitivity reaction in Spain.
Zubiaur P, Saiz-Rodríguez M, Villapalos-García G, Navares-Gómez M, Koller D, Abad-Santos F. | 09/4/2021 |
| Long non-coding RNA HCP5 in cancer. | Long non-coding RNA HCP5 in cancer.
Zou Y, Chen B. | 08/21/2021 |
| LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis. | LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B, Guan Q, Yan T, Zhang X, Xu W, Li J. | 07/17/2021 |
| LncRNA HCP5 promotes LAML progression via PSMB8-mediated PI3K/AKT pathway activation. | LncRNA HCP5 promotes LAML progression via PSMB8-mediated PI3K/AKT pathway activation.
Lei M, Jingjing Z, Tao J, Jianping M, Yuanxin Z, Jifeng W, Lianguo X, Lidong Z, Ying W. | 06/5/2021 |
| MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1alpha/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. | MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer.
Wu H, Liu B, Chen Z, Li G, Zhang Z., Free PMC Article | 04/13/2021 |
| Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway. | Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
Zhang YJ, Lu C. | 03/20/2021 |